We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-17.26%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.29B
AUM Growth
-$744M
Cap. Flow
+$126M
Cap. Flow %
3.81%
Top 10 Hldgs %
18.14%
Holding
1,378
New
105
Increased
487
Reduced
524
Closed
187

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$6.95M
2
NKE icon
Nike
NKE
+$5.91M
3
UNH icon
UnitedHealth
UNH
+$5.38M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$5.36M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.93M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Healthcare 13.38%
3 Financials 10.48%
4 Consumer Discretionary 8.32%
5 Communication Services 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
26
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$22M 0.67%
85,540
-16,174
-16% -$4.93M
ILMN icon
27
Illumina
ILMN
$28.8B
$21.9M 0.66%
82,358
-1,648
-2% -$461K
BMY icon
28
Bristol-Myers Squibb
BMY
$133B
$21.1M 0.64%
378,081
+14,026
+4% +$857K
BABA icon
29
Alibaba
BABA
$313B
$21M 0.64%
107,790
-12,712
-11% -$2.65M
WMT icon
30
Walmart Inc
WMT
$886B
$20.5M 0.62%
541,122
+56,568
+12% +$2.18M
INTC icon
31
Intel
INTC
$495B
$19.5M 0.59%
361,070
+8,570
+2% +$507K
PEP icon
32
PepsiCo
PEP
$188B
$19.5M 0.59%
162,282
+10,566
+7% +$1.43M
PG icon
33
Procter & Gamble
PG
$339B
$19.4M 0.59%
176,603
-276
-0.2% -$33.1K
NEE icon
34
NextEra Energy
NEE
$176B
$18.1M 0.55%
300,420
-364
-0.1% -$22.9K
NVDA icon
35
NVIDIA
NVDA
$5.31T
$17.1M 0.52%
2,592,280
-217,680
-8% -$1.37M
MA icon
36
Mastercard
MA
$494B
$16.7M 0.51%
69,230
+8,176
+13% +$2.43M
ABBV icon
37
AbbVie
ABBV
$433B
$16.3M 0.49%
213,731
+19,360
+10% +$1.65M
SBUX icon
38
Starbucks
SBUX
$120B
$16.2M 0.49%
246,238
+12,844
+6% +$1.04M
GLD icon
39
SPDR Gold Trust
GLD
$142B
$15.9M 0.48%
107,577
-5,139
-5% -$765K
UNH icon
40
UnitedHealth
UNH
$373B
$15.9M 0.48%
63,576
-19,545
-24% -$5.38M
HON icon
41
Honeywell
HON
$77.2B
$15.6M 0.47%
123,779
-1,646
-1% -$254K
SHV icon
42
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
$15.3M 0.46%
137,820
+21,421
+18% +$2.37M
TLT icon
43
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
$14.8M 0.45%
89,772
+76,420
+572% +$11.4M
CMCSA icon
44
Comcast
CMCSA
$88.6B
$14.8M 0.45%
430,070
+38,500
+10% +$1.62M
SHY icon
45
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$14.7M 0.45%
169,501
+50,677
+43% +$4.33M
IBM icon
46
IBM
IBM
$224B
$14.6M 0.44%
137,532
+30,559
+29% +$3.86M
BAC icon
47
Bank of America
BAC
$446B
$14.4M 0.44%
680,551
-134,923
-17% -$4.04M
MDT icon
48
Medtronic
MDT
$114B
$14.4M 0.44%
160,193
-6,338
-4% -$674K
MTUM icon
49
iShares MSCI USA Momentum Factor ETF
MTUM
$25.5B
$14.2M 0.43%
133,327
-31,254
-19% -$3.86M
EHC icon
50
Encompass Health
EHC
$12.4B
$14.1M 0.43%
276,290
-4,761
-2% -$275K

Similar funds

Oppenheimer & Co's Q1 2020 Portfolio in Review

As of Q1 2020, Oppenheimer & Co held 1,378 positions worth $3.29B, down 18% from $4.04B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $126M of net new capital in Q1 2020, opening 105 new positions and adding to 487 existing holdings. Its largest new stake was Hasbro: 50,954 shares worth $3.65M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Target, an estimated $6.95M trimmed.

  • Oppenheimer & Co's largest Q1 2020 buy was Hasbro: 50,954 shares worth $3.65M.
  • Oppenheimer & Co added most to Invesco QQQ Trust in Q1 2020, an estimated $24.5M increase.
  • Oppenheimer & Co's biggest Q1 2020 reduction was Target, cutting an estimated $6.95M.
  • Oppenheimer & Co fully exited Campbell Soup in Q1 2020, selling an estimated $3.76M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $3.29B portfolio in Q1 2020.
  • Oppenheimer & Co opened 105 new positions and closed 187 in Q1 2020.
  • Oppenheimer & Co's portfolio value fell 18% quarter-over-quarter to $3.29B.

Based on Oppenheimer & Co's 13F filing for Q1 2020, filed 8 May 2020.